Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Morgan Stanley Downgrades Core Laboratories to Underweight, Announces $20 Price Target

Morgan Stanley Downgrades Core Laboratories to Underweight, Announces $20 Price Target

Morgan Stanley analyst Connor Lynagh downgrades Core Laboratories (NYSE:CLB) from Equal-Weight to Underweight and announces $20 price target.

September 26, 2022

1 minute read

Morgan Stanley analyst Connor Lynagh downgrades Core Laboratories (NYSE:CLB) from Equal-Weight to Underweight and announces $20 price target.

The Latest Analyst Ratings for Western Midstream

August 29, 10:01 AM

Over the past 3 months, 9 analysts have published their opinion on Western Midstream (NYSE:WES) stock. These analysts…

June 13, 10:34 AM

Stellantis N.V. (NYSE: STLA) announced North America-based fleet management company Merchants Fleet would

September 21, 6:07 AM

HC Wainwright & Co. analyst Oren Livnat maintains Satsuma Pharmaceuticals (NASDAQ:STSA) with a Buy and raises the price target from $15 to $18.

January 13, 9:41 AM

Mizuho analyst Brett Linzey maintains Zurn Elkay Water (NYSE:ZWS) with a Buy and lowers the price target from $31 to $26.